Posters

VitroScan at SITC 2025: Ex vivo micro-tumor testing identifies patient-specific anti-tumor immune responses to T cell engager ubamatamab

Download

VitroScan at ENA 2025: Bispecific antibody ubamatamab induces patient-specific anti-tumor immune responses in an ex vivo platform for ovarian cancer

Download

VitroScan at ESMO 2025: Chemo Sensitivity Score using an ex vivo 3D micro-tumor testing platform to predict clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

Download

VitroScan at FOB 2025: Ex vivo 3D micro-tumor platform reveals patient-specific responses to bispecific antibodies and antibody-drug-conjugates

Download

VitroScan at ESMO 2024: Basket trial for chemotherapy response prediction for lung, bladder, and ovarian cancer patients

Download

VitroScan at AACR 2024: Absence of synergistic effects for PARPi and immunotherapy combinations in ex vivo 3D tumor testing for ovarian cancer patients

Download

VitroScan at AACR 2024: Ex vivo 3D tumor testing enables NSCLC patient stratification for chemo-, immuno-, and targeted therapy

Download

VitroScan at EACR 2024: Ex vivo micro tumor testing to assess patient-specific sensitivity to targeted therapies

Download

VitroScan at FOB 2024: Characterization of the tumor micro-environment in ex vivo 3D micro-tumor assays to identify translational markers for ovarian and lung cancer

Download

Home Insights Resources Posters